The Sinopharm COVID-19 vaccine (BBIBP-CorV) is the first China-made vaccine to be approved by the World Health Organisation (WHO) in December 2020. It is an inactivated vaccine, a tried-and-tested form of vaccine technology used in other well-established vaccines, such as the flu and hepatitis B vaccines.
The Sinopharm vaccine provides an alternative option for people in Singapore who have previously been found unsuitable to receive the mRNA options. (e.g. If a person has taken a dose of Pfizer/Moderna and has had an allergic reaction.) This is in line with efforts to enhance vaccination coverage against COVID-19 in Singapore.
The recommended age for the Sinopharm vaccine is 18 years and older.
As of 22 July 2021, IHH Healthcare Singapore has obtained approval from the Health Sciences Authority of Singapore to import the vaccine under the Special Access Route (SAR) scheme. The Sinopharm vaccine is priced at S$99 for 2 doses, inclusive of GST.
Please note that we are currently of stock for the Sinopharm vaccine. Stay tuned for more information as we work to replenish supplies.